Sign in
4

Changes in Ownership

ORAMED PHARMACEUTICALS INC. Filed Acc 0001213900-26-031015

Chief Scientific Officer acquired 119,558 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kidron Miriam Chief Scientific Officer 2026-03-17 Grant or award +119,558 1,568,222 D
Loading xslF345X06/ownership.xml…